神经调节蛋白-1对脓毒症大鼠心功能及炎症介质的影响
该研究将健康雄性SD大鼠随机分为三组(每组6只):假手术组、盲肠结扎穿孔(CLP)脓毒症组、NRG-1预处理组。NRG-1预处理组经尾静脉注射重组人神经调节蛋白-1(rhNRG-1)10 μg/kg,CLP组和假手术组给予等量生理盐水。CLP后24小时评估血流动力学、心肌形态及血清cTnT、TNF-α、IL-1β和心肌MIF水平。结果显示NRG-1预处理组MAP、LVSP、±dp/dt max均高于CLP组,cTnT、TNF-α、IL-1β及心肌MIF均低于CLP组,HE染色心肌病理改变较CLP组改善。
要点
- 脓毒症大鼠CLP后24小时,NRG-1预处理组MAP为125.78±8.15 mmHg,高于CLP组的113.05±5.85 mmHg(P<0.05)。
- NRG-1预处理组LVSP为151.27±6.79 mmHg,高于CLP组的139.39±8.05 mmHg(P<0.05)。
- NRG-1预处理组血清cTnT为206.37±67.28 ng/L,低于CLP组的344.13±80.95 ng/L(P<0.05)。
- NRG-1预处理组血清TNF-α为52.77±3.43 ng/L、IL-1β为40.25±5.48 ng/L,均低于CLP组的97.19±13.98 ng/L和56.05±6.88 ng/L(均P<0.05)。
- NRG-1预处理组心肌MIF为1.92±0.16 μg/L,低于CLP组的2.87±0.10 μg/L(P<0.05)。
适用人群与场景
- 健康雄性Sprague-Dawley(SD)大鼠,每组6只,共三组。
- 脓毒症模型采用盲肠结扎穿孔(CLP)建立。
- 假手术组除不结扎外行相同手术操作。
处置流程与药物剂量
- NRG-1预处理组经尾静脉注射重组人神经调节蛋白-1(rhNRG-1),剂量10 μg/kg。
- CLP组和假手术组经尾静脉给予等量生理盐水。
- CLP后24小时评估心功能、心肌形态及血清和心肌炎症介质水平。
研究设计与关键结果
- 研究类型:动物实验,健康雄性SD大鼠随机分为假手术组、CLP组和NRG-1预处理组,每组6只。
- 心功能:与假手术组相比,CLP组和NRG-1预处理组MAP、LVSP、±dp/dt max均显著降低;NRG-1预处理组MAP(125.78±8.15 mmHg vs. 113.05±5.85 mmHg)、LVSP(151.27±6.79 mmHg vs. 139.39±8.05 mmHg)、+dp/dt max(4389.59±332.38 kPa/s vs. 3706.85±451.31 kPa/s)、-dp/dt max(4291.42±323.72 kPa/s vs. 3691.17±515.44 kPa/s)均显著高于CLP组(均P<0.05)。
- 心肌损伤:与假手术组相比,CLP组和NRG-1预处理组血清cTnT均显著升高;NRG-1预处理组血清cTnT(206.37±67.28 ng/L vs. 344.13±80.95 ng/L)显著低于CLP组(P<0.05);HE染色显示NRG-1预处理组心肌病理改变较CLP组改善。
- 炎症介质:与假手术组相比,CLP组和NRG-1预处理组血清TNF-α、IL-1β及心肌MIF均显著升高;NRG-1预处理组TNF-α(52.77±3.43 ng/L vs. 97.19±13.98 ng/L)、IL-1β(40.25±5.48 ng/L vs. 56.05±6.88 ng/L)、MIF(1.92±0.16 μg/L vs. 2.87±0.10 μg/L)均低于CLP组(均P<0.05)。
证据类型、等级与局限
- 证据类型:动物实验(大鼠脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在大鼠CLP脓毒症模型中,CLP后24小时NRG-1预处理可改善心功能、减轻心肌损伤并降低炎症介质水平。
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the protective effect of neuregulin-1 (NRG-1) on heart function and myocardium in rats with sepsis and its mechanism.
METHODS: Healthy male Sprague-Dawly (SD) rats were divided into three groups according to random number table method, with 6 rats in each group. Sepsis model was established by cecal ligation and puncture (CLP group); rats in sham operation group (sham group) underwent the same procedure except ligation. Rats in NRG-1 pre-treatment group (NRG group) were intravenously injected with recombinant human NGR-1 (rhNRG-1) at the dose of 10 μg/kg through tail vein; rats in CLP group and sham group were treated with the same amount of saline. At 24 hours after CLP, hemodynamic method was used to evaluate the cardiac function, and myocardial morphology was observed with hematoxylin and eosin (HE) staining, enzyme linked immunosorbent assay (ELISA) was used to detect the levels of cardiac troponin T (cTnT), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) in serum and macrophage migration inhibitor factor (MIF) in myocardial tissue.
RESULTS: (1) heart function: compared with the sham group, the mean arterial pressure (MAP), left ventricular systolic pressure (LVSP) and left ventricular pressure maximal rate of rise and fall (±dp/dt max) were significantly decreased in CLP group and NRG group, while the MAP, LVSP and ±dp/dt max in NRG group were significantly higher than those in CLP group [MAP (mmHg, 1 mmHg = 0.133 kPa): 125.78±8.15 vs. 113.05±5.85, LVSP (mmHg): 151.27±6.79 vs. 139.39±8.05, +dp/dt max (kPa/s): 4 389.59±332.38 vs. 3 706.85±451.31, -dp/dt max (kPa/s): 4 291.42±323.72 vs. 3 691.17±515.44, all P < 0.05]. (2) Myocardial injury: compared with the sham group, the levels of serum cTnT in CLP group and NRG group were significantly increased, while the levels of serum cTnT in NRG group were significantly lower than those in CLP group (ng/L: 206.37±67.28 vs. 344.13±80.95, P < 0.05), and the HE staining showed that myocardial pathological changes in NRG group were improved compared with the CLP group. (3) Inflammatory mediators level: compared with the sham group, the levels of serum TNF-α, IL-1β and myocardial MIF were significantly increased in CLP group and NRG group, while the indicators in NRG group were lower than those in CLP group [TNF-α (ng/L): 52.77±3.43 vs. 97.19±13.98, IL-1β (ng/L): 40.25±5.48 vs. 56.05±6.88, MIF (μg/L): 1.92±0.16 vs. 2.87±0.10, all P < 0.05].
CONCLUSIONS: NRG-1 can reduce circulating levels of inflammatory factors in rats with sepsis, adjust myocardial MIF level, and alleviate myocardial cell injury, thereby improving cardiac function, and play a role in myocardial protection.
参考来源
- Zhou Q, Wang L, Wang X, et al. [Effect of neuregulin-1 on heart function and inflammatory mediators in rats with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29402363. doi:10.3760/cma.j.issn.2095-4352.2018.02.009
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。